nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—PGR—polycystic ovary syndrome	0.812	1	CbGaD
Allylestrenol—PGR—corpus luteum—polycystic ovary syndrome	0.0285	0.28	CbGeAlD
Allylestrenol—PGR—ovarian follicle—polycystic ovary syndrome	0.0223	0.219	CbGeAlD
Allylestrenol—ESR1—ovarian follicle—polycystic ovary syndrome	0.0175	0.171	CbGeAlD
Allylestrenol—CYP3A4—urine—polycystic ovary syndrome	0.00407	0.04	CbGeAlD
Allylestrenol—ESR1—embryo—polycystic ovary syndrome	0.00236	0.0232	CbGeAlD
Allylestrenol—PGR—endometrium—polycystic ovary syndrome	0.00221	0.0217	CbGeAlD
Allylestrenol—PGR—uterus—polycystic ovary syndrome	0.00204	0.02	CbGeAlD
Allylestrenol—PGR—pituitary gland—polycystic ovary syndrome	0.002	0.0196	CbGeAlD
Allylestrenol—PGR—adipose tissue—polycystic ovary syndrome	0.00199	0.0195	CbGeAlD
Allylestrenol—PGR—adrenal gland—polycystic ovary syndrome	0.00179	0.0175	CbGeAlD
Allylestrenol—ESR1—endometrium—polycystic ovary syndrome	0.00173	0.0169	CbGeAlD
Allylestrenol—PGR—female gonad—polycystic ovary syndrome	0.00166	0.0163	CbGeAlD
Allylestrenol—PGR—vagina—polycystic ovary syndrome	0.00165	0.0162	CbGeAlD
Allylestrenol—ESR1—uterus—polycystic ovary syndrome	0.00159	0.0156	CbGeAlD
Allylestrenol—ESR1—pituitary gland—polycystic ovary syndrome	0.00156	0.0153	CbGeAlD
Allylestrenol—ESR1—adipose tissue—polycystic ovary syndrome	0.00156	0.0153	CbGeAlD
Allylestrenol—PGR—endocrine gland—polycystic ovary syndrome	0.00155	0.0152	CbGeAlD
Allylestrenol—ESR1—adrenal gland—polycystic ovary syndrome	0.0014	0.0137	CbGeAlD
Allylestrenol—ESR1—female gonad—polycystic ovary syndrome	0.0013	0.0128	CbGeAlD
Allylestrenol—ESR1—vagina—polycystic ovary syndrome	0.00129	0.0127	CbGeAlD
Allylestrenol—Levonorgestrel—SRD5A1—polycystic ovary syndrome	0.00126	0.135	CrCbGaD
Allylestrenol—ESR1—endocrine gland—polycystic ovary syndrome	0.00121	0.0119	CbGeAlD
Allylestrenol—Oxandrolone—AR—polycystic ovary syndrome	0.000946	0.102	CrCbGaD
Allylestrenol—Ethynodiol—PGR—polycystic ovary syndrome	0.000875	0.0939	CrCbGaD
Allylestrenol—Norelgestromin—PGR—polycystic ovary syndrome	0.000826	0.0886	CrCbGaD
Allylestrenol—Desogestrel—PGR—polycystic ovary syndrome	0.000796	0.0853	CrCbGaD
Allylestrenol—Norgestimate—PGR—polycystic ovary syndrome	0.000744	0.0798	CrCbGaD
Allylestrenol—Desogestrel—SHBG—polycystic ovary syndrome	0.000744	0.0797	CrCbGaD
Allylestrenol—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000676	0.00663	CbGeAlD
Allylestrenol—Levonorgestrel—PGR—polycystic ovary syndrome	0.000456	0.0489	CrCbGaD
Allylestrenol—Levonorgestrel—SHBG—polycystic ovary syndrome	0.000426	0.0457	CrCbGaD
Allylestrenol—Levonorgestrel—AR—polycystic ovary syndrome	0.000373	0.04	CrCbGaD
Allylestrenol—Norethindrone—PGR—polycystic ovary syndrome	0.000369	0.0396	CrCbGaD
Allylestrenol—Norethindrone—SHBG—polycystic ovary syndrome	0.000345	0.037	CrCbGaD
Allylestrenol—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000328	0.0351	CrCbGaD
Allylestrenol—Levonorgestrel—CYP19A1—polycystic ovary syndrome	0.000312	0.0335	CrCbGaD
Allylestrenol—Methyltestosterone—AR—polycystic ovary syndrome	0.000287	0.0308	CrCbGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000267	0.00351	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—NR3C1—polycystic ovary syndrome	0.00026	0.00342	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.00026	0.00341	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—BAX—polycystic ovary syndrome	0.000259	0.00341	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000258	0.00338	CbGpPWpGaD
Allylestrenol—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000258	0.00338	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—YAP1—polycystic ovary syndrome	0.000255	0.00335	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—NRG1—polycystic ovary syndrome	0.000253	0.00332	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—GAB1—polycystic ovary syndrome	0.000251	0.0033	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.00025	0.00329	CbGpPWpGaD
Allylestrenol—Methyltestosterone—CYP19A1—polycystic ovary syndrome	0.00024	0.0258	CrCbGaD
Allylestrenol—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000237	0.00311	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.000232	0.00304	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—LSM5—polycystic ovary syndrome	0.000229	0.00301	CbGpPWpGaD
Allylestrenol—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.000228	0.00299	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—INS—polycystic ovary syndrome	0.000227	0.00298	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—TNRC6B—polycystic ovary syndrome	0.000225	0.00295	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—PGR—polycystic ovary syndrome	0.000223	0.00292	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000221	0.0029	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—LEP—polycystic ovary syndrome	0.000219	0.00288	CbGpPWpGaD
Allylestrenol—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000219	0.00287	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—IRS2—polycystic ovary syndrome	0.000217	0.00285	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000215	0.00282	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000215	0.00282	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SAP30L—polycystic ovary syndrome	0.000213	0.0028	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000198	0.00261	CbGpPWpGaD
Allylestrenol—ESR1—Leptin signaling pathway—IRS1—polycystic ovary syndrome	0.000195	0.00257	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ZNF205—polycystic ovary syndrome	0.000194	0.00255	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ZNF430—polycystic ovary syndrome	0.000194	0.00255	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—BCL2—polycystic ovary syndrome	0.000191	0.00251	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—IRS1—polycystic ovary syndrome	0.000189	0.00248	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000185	0.00243	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000183	0.0024	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—TEAD2—polycystic ovary syndrome	0.000181	0.00238	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—PRL—polycystic ovary syndrome	0.000181	0.00237	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.00018	0.00236	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000179	0.00235	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—AKT2—polycystic ovary syndrome	0.000175	0.0023	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000175	0.0023	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000174	0.00228	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000166	0.00218	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ADARB1—polycystic ovary syndrome	0.000165	0.00217	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000164	0.00215	CbGpPWpGaD
Allylestrenol—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000162	0.00212	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000155	0.00204	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000154	0.00202	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000152	0.002	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000151	0.00199	CbGpPWpGaD
Allylestrenol—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000151	0.00198	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000149	0.00196	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—NRG1—polycystic ovary syndrome	0.000148	0.00195	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000148	0.00195	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000144	0.00189	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000134	0.00177	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—LSM5—polycystic ovary syndrome	0.000134	0.00176	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NPB—polycystic ovary syndrome	0.00013	0.00171	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—RPL37A—polycystic ovary syndrome	0.000129	0.00169	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—IRS2—polycystic ovary syndrome	0.000127	0.00167	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000126	0.00166	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000126	0.00166	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000125	0.00164	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SAP30L—polycystic ovary syndrome	0.000125	0.00164	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000123	0.00161	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000122	0.0016	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000122	0.0016	CbGpPWpGaD
Allylestrenol—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000122	0.0016	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00012	0.00158	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000118	0.00155	CbGpPWpGaD
Allylestrenol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000117	0.00154	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000112	0.00147	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—IRS1—polycystic ovary syndrome	0.000111	0.00146	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000109	0.00143	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000109	0.00143	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000107	0.0014	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—TEAD2—polycystic ovary syndrome	0.000106	0.0014	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000105	0.00138	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—AKT2—polycystic ovary syndrome	0.000103	0.00135	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000102	0.00133	CbGpPWpGaD
Allylestrenol—ESR1—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	9.91e-05	0.0013	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	9.89e-05	0.0013	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	9.87e-05	0.0013	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	9.86e-05	0.0013	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	9.83e-05	0.00129	CbGpPWpGaD
Allylestrenol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	9.7e-05	0.00127	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	9.59e-05	0.00126	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—INHBB—polycystic ovary syndrome	9.35e-05	0.00123	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	9.21e-05	0.00121	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	9.02e-05	0.00119	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FLT4—polycystic ovary syndrome	8.74e-05	0.00115	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PDE3B—polycystic ovary syndrome	8.73e-05	0.00115	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—YAP1—polycystic ovary syndrome	8.65e-05	0.00114	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	8.64e-05	0.00113	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	8.64e-05	0.00113	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	8.57e-05	0.00113	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	8.06e-05	0.00106	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	7.97e-05	0.00105	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	7.95e-05	0.00104	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FSHR—polycystic ovary syndrome	7.95e-05	0.00104	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—IL6—polycystic ovary syndrome	7.92e-05	0.00104	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	7.64e-05	0.001	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	7.64e-05	0.001	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	7.63e-05	0.001	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	7.57e-05	0.000994	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	7.48e-05	0.000982	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	7.47e-05	0.000982	CbGpPWpGaD
Allylestrenol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	7.33e-05	0.000963	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	7.27e-05	0.000955	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	7.16e-05	0.00094	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	7.14e-05	0.000938	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FST—polycystic ovary syndrome	7.09e-05	0.000931	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	7.04e-05	0.000925	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	7e-05	0.000919	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	6.92e-05	0.000908	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	6.91e-05	0.000907	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	6.89e-05	0.000904	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	6.76e-05	0.000888	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	6.75e-05	0.000887	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	6.65e-05	0.000873	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	6.64e-05	0.000872	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	6.55e-05	0.00086	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	6.55e-05	0.00086	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	6.48e-05	0.000851	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	6.37e-05	0.000837	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	6.37e-05	0.000837	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	6.26e-05	0.000822	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	6.18e-05	0.000812	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	6.08e-05	0.000798	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	6.02e-05	0.000791	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	5.96e-05	0.000783	CbGpPWpGaD
Allylestrenol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	5.94e-05	0.000781	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—AR—polycystic ovary syndrome	5.87e-05	0.000771	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	5.79e-05	0.000761	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	5.79e-05	0.00076	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	5.63e-05	0.000739	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	5.62e-05	0.000739	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	5.6e-05	0.000735	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	5.55e-05	0.000729	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	5.49e-05	0.000721	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	5.3e-05	0.000697	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.25e-05	0.00069	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.18e-05	0.00068	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	5.13e-05	0.000674	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.12e-05	0.000673	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	5.08e-05	0.000667	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.04e-05	0.000662	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	4.96e-05	0.000652	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	4.75e-05	0.000624	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	4.67e-05	0.000613	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	4.65e-05	0.00061	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	4.57e-05	0.0006	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	4.57e-05	0.0006	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	4.49e-05	0.000589	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	4.48e-05	0.000588	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PGR—polycystic ovary syndrome	4.43e-05	0.000582	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.39e-05	0.000576	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	4.36e-05	0.000572	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	4.27e-05	0.00056	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.25e-05	0.000558	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.23e-05	0.000556	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.18e-05	0.000548	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	4.16e-05	0.000546	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.11e-05	0.000539	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	4.06e-05	0.000533	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	4.04e-05	0.000531	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	4.02e-05	0.000528	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	3.98e-05	0.000523	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.97e-05	0.000521	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.84e-05	0.000505	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	3.8e-05	0.0005	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	3.78e-05	0.000496	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	3.72e-05	0.000489	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—PPARG—polycystic ovary syndrome	3.68e-05	0.000483	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.63e-05	0.000477	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	3.57e-05	0.000468	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	3.54e-05	0.000464	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	3.5e-05	0.00046	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—AR—polycystic ovary syndrome	3.45e-05	0.000453	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	3.41e-05	0.000447	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	3.41e-05	0.000447	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.34e-05	0.000438	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	3.32e-05	0.000435	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	3.3e-05	0.000434	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	3.28e-05	0.00043	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	3.26e-05	0.000428	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.17e-05	0.000416	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.16e-05	0.000415	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	3.11e-05	0.000409	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	3.01e-05	0.000396	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.96e-05	0.000388	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.91e-05	0.000382	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	2.88e-05	0.000379	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	2.81e-05	0.000369	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	2.79e-05	0.000366	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	2.75e-05	0.000361	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	2.69e-05	0.000354	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	2.69e-05	0.000354	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.68e-05	0.000352	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.68e-05	0.000352	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	2.56e-05	0.000336	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.49e-05	0.000327	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	2.45e-05	0.000322	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	2.36e-05	0.00031	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.36e-05	0.00031	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—INS—polycystic ovary syndrome	2.35e-05	0.000308	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	2.34e-05	0.000307	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	2.27e-05	0.000298	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	2.27e-05	0.000298	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.26e-05	0.000296	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.22e-05	0.000291	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	2.16e-05	0.000284	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.16e-05	0.000283	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.14e-05	0.000281	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.06e-05	0.00027	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.04e-05	0.000268	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.96e-05	0.000257	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.95e-05	0.000256	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.92e-05	0.000253	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.82e-05	0.000239	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.74e-05	0.000228	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.65e-05	0.000216	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	1.61e-05	0.000212	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.58e-05	0.000208	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.55e-05	0.000203	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.5e-05	0.000197	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.48e-05	0.000195	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.44e-05	0.000189	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	1.38e-05	0.000182	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.38e-05	0.000181	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	1.38e-05	0.000181	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.34e-05	0.000175	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.33e-05	0.000175	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.33e-05	0.000175	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.29e-05	0.000169	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.27e-05	0.000166	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.24e-05	0.000162	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.22e-05	0.00016	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.15e-05	0.000151	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.14e-05	0.000149	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	1.03e-05	0.000135	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TH—polycystic ovary syndrome	9.82e-06	0.000129	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	9.55e-06	0.000125	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	8.98e-06	0.000118	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.7e-06	0.000114	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.02e-06	0.000105	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	7.64e-06	0.0001	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.24e-06	9.51e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.75e-06	8.87e-05	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	6.02e-06	7.9e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.47e-06	7.19e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.4e-06	7.09e-05	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.37e-06	7.05e-05	CbGpPWpGaD
